Zainulabid, U. A. (2024). The persistence of antibodies in ESRD patients 12 months after the BNT162B2 vaccine booster dose. UniKL Royal College of Medicine Perak (UniKL RCMP).
シカゴスタイル引用形Zainulabid, Ummu Afeera. The Persistence of Antibodies in ESRD Patients 12 Months After the BNT162B2 Vaccine Booster Dose. UniKL Royal College of Medicine Perak (UniKL RCMP), 2024.
MLA引用形式Zainulabid, Ummu Afeera. The Persistence of Antibodies in ESRD Patients 12 Months After the BNT162B2 Vaccine Booster Dose. UniKL Royal College of Medicine Perak (UniKL RCMP), 2024.
警告: この引用は必ずしも正確ではありません.